NCT03081416View on ClinicalTrials.gov

"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2017

Conditions
HeadacheIntranasal Ketamine
Interventions
DRUG

Ketamine

Intranasal ketamine administration

DRUG

Normal saline

DRUG

Metoclopramide

Standard therapy

DRUG

Ketorolac

standard therapy

DRUG

Dexamethasone

Standard therapy

DRUG

Benadryl

Standard therapy

Trial Locations (1)

78236

Brooke Army Medical Center, San Antonio

All Listed Sponsors
lead

Brooke Army Medical Center

FED

NCT03081416 - "THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department" | Biotech Hunter | Biotech Hunter